Common origins of MDA-MB-435 cells from various sources with those shown to have melonoma properties
暂无分享,去创建一个
Susan J. Ramus | Mark Waltham | Ian G. Campbell | Jane E. Armes | M. Waltham | I. Campbell | J. Rae | E. Thompson | S. Ramus | James M. Rae | J. Armes | Robert Clarke | Robert J. Barndt | Michael D. Johnson | Erik W. Thompson | R. Clarke | R. Barndt
[1] G. Ellison,et al. Further evidence to support the melanocytic origin of MDA-MB-435 , 2002, Molecular pathology : MP.
[2] C Caldas,et al. Molecular cytogenetic analysis of breast cancer cell lines , 2000, British Journal of Cancer.
[3] G. Nicolson,et al. Multiple phenotypic divergence of mammary adenocarcinoma cell clones , 1984, Clinical & Experimental Metastasis.
[4] T. Shike,et al. Animal models. , 2001, Contributions to nephrology.
[5] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[6] G. Nicolson,et al. Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumors , 2004, Clinical & Experimental Metastasis.
[7] J. Talmadge,et al. Relationship of macrophage content, immunogenicity, and metastatic potential of a murine osteosarcoma of recent origin , 2005, Clinical & Experimental Metastasis.
[8] J. Scheys,et al. Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples. , 2003, Pharmacogenetics.
[9] T. Hsu,et al. Cytogenetic analysis on eight human breast tumor cell lines: high frequencies of 1q, 11q and HeLa-like marker chromosomes. , 1981, Cancer genetics and cytogenetics.
[10] G. Nicolson,et al. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to Adriamycin, 5-fluoro-2′-deoxyuridine and methotrexate treatment in vitro , 1983, Clinical & Experimental Metastasis.
[11] Nasreen S Jessani,et al. Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] Jeffrey W. Smith,et al. Gene expression profiling of tumor xenografts: In vivo analysis of organ‐specific metastasis , 2003, International journal of cancer.
[13] M. Waltham,et al. LCC15-MB Cells are MDA-MB-435: A Review of Misidentified Breast and prostate cell lines , 2004, Clinical & Experimental Metastasis.
[14] T. Hirano,et al. Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis. , 2001, Cancer genetics and cytogenetics.
[15] J N Weinstein,et al. A protein expression database for the molecular pharmacology of cancer , 1997, Electrophoresis.
[16] M. Gottesman,et al. MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer. , 1996, British Journal of Cancer.
[17] P. Drew,et al. Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. , 2002, International journal of oncology.
[18] G. Nicolson,et al. Heterogeneous response and clonal drift of sensitivities of metastatic 13762NF mammary adenocarcinoma clones to gamma-radiation in vitro. , 1983, Cancer research.
[19] J. Russo,et al. In Vitro Models for Human Breast Cancer , 2004 .
[20] J. Price,et al. Studies of human breast cancer metastasis using nude mice , 1990, Cancer and Metastasis Reviews.
[21] J. Price. Analyzing the metastatic phenotype , 1994, Journal of cellular biochemistry.
[22] A. Whittemore,et al. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases. , 2003, Cancer research.
[23] Gordon B Mills,et al. Lineage Infidelity of MDA-MB-435 Cells , 2004, Cancer Research.
[24] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[25] J Piper,et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.
[26] D. Scudiero,et al. Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen. , 1998, Journal of the National Cancer Institute.
[27] C. Gilles,et al. The Epithelial to Mesenchymal Transition and Metastatic Progression in Carcinoma , 1996 .
[28] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Waltham,et al. Epidermal Growth Factor-Induced Epithelio-Mesenchymal Transition in Human Breast Carcinoma Cells , 2003, Laboratory Investigation.
[30] M. Hendrix,et al. Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells , 2000, Breast Cancer Research.
[31] J. Price,et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.